SEA Healthcare and Pharma Conference 2025: Pioneering the future of healthcare in the region

Qube Integrated Malaysia Sdn. Bhd., the organiser of SEACare 2025, is proud to announce the inaugural SEA Healthcare and Pharma Conference 2025, co-organised by the National Cancer Society Malaysia (NCSM) and Five Pillar Venture Capital Sdn. Bhd. This event marks another milestone for SEACare, which was acquired by Qube in 2024.

The SEA Healthcare and Pharma Conference 2025 will be held alongside the SEACare 2025 exhibition from 23 to 25 April 2025 at MITEC, Kuala Lumpur. Delegates who attend all three days of the conference will receive a certificate of attendance and are eligible for 20 CPD points each from the Malaysian Medical Association (MMA) and the Malaysian Pharmacists Society (MPS).

As Malaysia advances its healthcare agenda with a focus on digital integration, sustainable funding, and policy reforms, the conference aims to drive impactful discussions and strategic collaborations. With the Health Transformation Office (HTO) implementing key Health White Paper initiatives and AI-powered innovations reshaping patient care, the conference will spotlight the intersection of technology, policy, and investment in building a future-ready healthcare system.

Expert-led conference curated by industry leaders and endorsed by MMA and MPS

Professor Eli Renganathan, Public Health and Policy

The SEA Healthcare and Pharma Conference 2025 is guided by a distinguished Steering Committee composed of some of the most prominent figures in the healthcare sector. Among them are Dato’ Dr. Saunthari Somasundaram, President of NCSM and Co-chairperson of Non-Communicable Diseases (NCD) Malaysia; Dr. Muralitharan Paramasua, the Chief Executive of Medical Device Authority (MDA) under the Ministry of Health Malaysia; Dr. Noraryana Binti Hassan, the Deputy Director (NCD) at the Disease Control Division of the Ministry of Health Malaysia; Professor Eli Renganathan, Public Health and Policy; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia; and Zainul Alam Abdul Kadir, Business Development Director at Frost & Sullivan Malaysia. Their collective expertise spans medical research, clinical practice, public health policy, and industry leadership, ensuring the conference agenda remains insightful, relevant, and forward-thinking.

Dr. Noraryana Binti Hassan, Deputy Director (NCD), Disease Control Division, Ministry of Health Malaysia said “This conference stands out for its comprehensive approach, covering the entire disease continuum with case studies in areas like diabetes and cancer while focusing on core health system pillars such as financing and system strengthening. By bridging clinical practice with policy discussions, it offers valuable insights for a diverse range of stakeholders, from healthcare providers to policymakers, who can apply these learnings within their own contexts across the region.”

Dr. Noraryana Binti Hassan, the Deputy Director at the Disease Control Division of the Ministry of Health Malaysia

World-Class speaker line-up driving key discussions

The conference will feature a comprehensive programme covering key topics such as:

• Healthcare Transformation: Exploring innovative healthcare delivery models, policy shifts, and strategies to strengthen health systems.

• Healthcare Financing and Policy: Examining sustainable financing strategies, universal healthcare coverage, public-private partnerships, and value-based care delivery.

• Digital Health and AI Integration: Highlighting advancements in AI, digital health solutions, cloud computing, and their impact on patient care and healthcare accessibility.

Renowned speakers, Hoo Ling Lee, Regional CEO of KPJ Healthcare Bhd; Dr. Yap Wei Aun, CEO of the Health Transformation Office (HTO), Ministry of Health Malaysia; and Dr. Mahesh Appannan, Director of Digital Health, Ministry of Health Malaysia, will share their insights on these pressing topics.

Associate Professor Dr. Murallitharan M., Organising Chairman of SEA Healthcare and Pharma Conference 2025 and Managing Director of the National Cancer Society Malaysia (NCSM) said “The conference is designed to address the most pressing developments in healthcare. By exploring advancements in digital health, AI-driven innovations, and sustainable financing strategies, the event will serve as a catalyst for transformative change in the regional healthcare landscape. These discussions aim to equip stakeholders with valuable insights and practical solutions to navigate the evolving challenges of the industry in the coming years. ”

Beyond Business: Merging social impact and innovation

SEACare 2025 redefines healthcare trade events by merging business with social impact and investment-driven innovation. In collaboration with NCSM, it is Malaysia’s first healthcare trade event to dedicate a portion of its proceeds to supporting cancer care and awareness, reinforcing the event’s commitment to driving healthcare progress beyond commercial interests.

Richard Teo, Executive Chairman of Qube said “The SEA Healthcare and Pharma Conference 2025 marks a significant milestone as SEACare’s first-ever conference, designed to go beyond a traditional trade event by fostering critical dialogue, collaboration, and innovation. This conference reflects SEACare’s evolution not just as a platform for business opportunities but as a driver of transformative ideas that will shape the future of healthcare in the region.”

Registration Fee:

• HRD Claimable & Local / Self-Paid Delegate Pass (3 days): RM 3,900
• International Delegate Pass (3 days): USD 1,000 (≈ RM 4,500)
• Single-Day Pass: RM 1,300 per dayThe SEA Healthcare and Pharma Conference 2025 is a must-attend event for healthcare professionals, investors, and policymakers looking to drive meaningful change. To register, visit https://training.cancer.org.my/seacare-registration-form/